BARON SILVER STEVENS FINANCIAL ADVISORS, LLC
Position in MRK — Merck & Co., Inc.
CIK 1851395
Boca Raton, FL
Position in MRK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$894,874
+$80,391 QoQ
Shares Held
6,964
+2.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.08%
of 13F equity value
Holder Rank
#2,213
of 3,769 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BARON SILVER STEVENS FINANCIAL ADVISORS, LLC holds $5,410,143 across 7 Drug Manufacturers - General names. MRK ranks #4 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
5,253 | $1,334,104 | |
| 2 | LLY |
ELI LILLY & Co
|
775 | $929,558 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
7,173 | $906,236 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
6,964 | $894,874 | |
| 5 | PFE |
Pfizer Inc
|
22,560 | $543,244 | |
| 6 | ABBV |
AbbVie Inc.
|
1,986 | $499,757 | |
| 7 | AMGN |
Amgen Inc
|
835 | $302,370 |
All Filings in MRK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $894,874 | 6,964 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $814,483 | 6,771 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $438,934 | 4,170 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $353,009 | 4,206 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $383,609 | 4,846 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $404,727 | 4,509 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $567,433 | 5,704 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $630,825 | 5,555 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $627,666 | 5,070 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $753,698 | 5,712 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $623,376 | 5,718 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $569,107 | 5,528 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $654,953 | 5,676 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $560,568 | 5,269 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $588,035 | 5,300 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $456,436 | 5,300 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $522,586 | 5,732 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $400,896 | 4,886 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $369,941 | 4,827 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $319,292 | 4,251 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $358,986 | 4,616 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $266,885 | 3,462 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $287,935 | 3,520 | Shares | Sole | 2021-03-19 | |
| No filing history on record for this holder in this stock. | ||||||